Location: Home  >>   Sections >> Nanomedicines

Nanomedicines
A Section of Pharmaceutical Frontiers

Section Information

The section “Nanomedicines” offers a home to researchers concerned with the biophysical, chemical, biochemical, and biological properties of micro and nanodelivery systems, modified biopharmaceuticals, advanced therapy medicinal products and nanomaterials. This includes their design, manufacture and evaluation. Our main focus is applied research at the interface between academia and industry addressing current challenges in the development and synthesis of more effective and safe nanomedicines. We cover a wide range of studies dealing with pharmaceutical, medical and environmental aspects of drug design and formulation. Each manuscript considered for publication must provide new insights in one of the above mentioned areas. The novelty should be explained by the authors in the cover letter.

Section Editorial Board

Professor Ana Proykova
University of Sofia; Science Director of the Centre of Excellence UNITe (Universities for science and technology in the e-society); Head, High Performance Computing Laboratory, Sofia Tech Park, Bulgaria

Professor Marcos Luciano Bruschi
Laboratory of R&D of Drug Delivery Systems, Department of Pharmacy, State University of Maringa, Av. Colombo, nº 5790, CEP 87020-900, Maringá, Brazil

Professor Tivadar Feczkó
Research Centre for Natural Sciences, Institute of Materials and Environmental Chemistry, Hungarian Academy of Sciences; Research Institute of Biomolecular and Chemical Engineering, University of Pannonia , Hungary

Section Editor-in-Chief

  • Dr. Matthias G. Wacker

    Department of Pharmaceutical Technology and Nanosciences, Fraunhofer-Institute for Molecular Biology and Applied Ecology, Germany

    Matthias.wacker@nanomedicines.de

Copyright © 2019 Hapres Co., Ltd. Privacy Policy | Terms and Conditions